These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31986932)
1. Early detection and imaging strategies to reveal and target developing pancreatic cancer. Crawford HC; Wallace MB; Storz P Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932 [No Abstract] [Full Text] [Related]
2. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker? Babic A; Wolpin BM Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295 [No Abstract] [Full Text] [Related]
3. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925 [TBL] [Abstract][Full Text] [Related]
4. Prognostic markers in pancreatic ductal adenocarcinomas. Hezel AF; Bardeesy N Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287 [No Abstract] [Full Text] [Related]
5. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients]. Béchade D Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836 [TBL] [Abstract][Full Text] [Related]
6. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913 [TBL] [Abstract][Full Text] [Related]
7. Detection of High-Grade Pancreatic Intraepithelial Neoplasia without Morphological Changes of the Main Pancreatic Duct over a Long Period: Importance for Close Follow-Up for Confirmation. Yamao K; Takenaka M; Nakai A; Omoto S; Kamata K; Minaga K; Miyata T; Imai H; Sakurai T; Watanabe T; Nishida N; Matsumoto I; Takeyama Y; Chikugo T; Kudo M Oncology; 2017; 93 Suppl 1():81-86. PubMed ID: 29258080 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic intraepithelial neoplasia revisited and updated. Sipos B; Frank S; Gress T; Hahn S; Klöppel G Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer and cancer screening programs: from nihilism to hope. Pezzilli R; Corinaldesi R; Morselli-Labate AM JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511 [No Abstract] [Full Text] [Related]
10. [Precursors to pancreatic cancer]. Søreide K; Immervoll H; Molven A Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881 [TBL] [Abstract][Full Text] [Related]
11. Urine test can detect early stage pancreatic cancer. Bagcchi S Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762 [No Abstract] [Full Text] [Related]
12. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230 [TBL] [Abstract][Full Text] [Related]
13. Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma. Jarboe EA; Layfield LJ Diagn Cytopathol; 2011 Aug; 39(8):575-81. PubMed ID: 20730891 [TBL] [Abstract][Full Text] [Related]
14. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects. Chari ST; Sharma A; Maitra A Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886 [No Abstract] [Full Text] [Related]
15. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Klöppel G; Lüttges J Curr Gastroenterol Rep; 2004 Apr; 6(2):111-8. PubMed ID: 15191688 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic Ultrasound-Guided Fine-Needle Biopsies From Pancreatic Ductal Adenocarcinomas Can Be Used to Quantify PD-L1. Gleeson FC; Zhang L; Roden AC; Levy MJ Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1535-1536. PubMed ID: 29306039 [No Abstract] [Full Text] [Related]
17. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma. Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812 [TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883 [TBL] [Abstract][Full Text] [Related]
19. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
20. High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer. Yokode M; Akita M; Fujikura K; Kim MJ; Morinaga Y; Yoshikawa S; Terada T; Matsukiyo H; Tajiri T; Abe-Suzuki S; Itoh T; Hong SM; Zen Y Histopathology; 2018 Aug; 73(2):247-258. PubMed ID: 29660164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]